webinar register page

ISARIC Evidence Forum on use of convalescent plasma in hospitalised patients
Plasma from patients who have recovered from SARS-CoV-2 infection (convalescent plasma) contains antibodies that can bind to and neutralise the virus. Infusion of convalescent plasma containing high concentrations of neutralising antibody may theoretically accelerate clearance of the virus and clinical improvement. Although convalescent plasma has been widely used in patients admitted to hospital with COVID-19, data from randomised controlled trials in this patient group have, until recently, been limited.

This webinar provides evidence from randomised controlled trials of the safety and efficacy of convalescent plasma in patients hospitalised for COVID-19.

Jun 10, 2021 09:00 AM in London

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: ISARIC.